Ian G. McKeith British researcher
McKeith, I. G.
McKeith, Ian G.
McKeith, I. G. (Ian G.)
McKeith, Ian
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
MacKeith, Ian G.
VIAF ID: 46914740 (Personal)
Permalink: http://viaf.org/viaf/46914740
Preferred Forms
-
100 0 _
‡a
Ian G. McKeith
‡c
British researcher
-
100 1 _ ‡a MacKeith, Ian G.
-
200 _ |
‡a
McKeith
‡b
Ian G.
-
100 1 _ ‡a McKeith, I. G
-
100 1 _
‡a
McKeith, I. G.
-
100 1 _ ‡a McKeith, I. G. ‡q (Ian G.)
-
100 1 0
‡a
McKeith, I. G.
‡q
(Ian G.)
-
100 1 _ ‡a McKeith, I. G. ‡q (Ian G.)
-
100 1 _
‡a
McKeith, Ian
-
100 1 _ ‡a McKeith, Ian G.
4xx's: Alternate Name Forms (17)
Works
| Title | Sources |
|---|---|
| Dementia with Lewy bodies : clinical, pathological, and treatment issues |
|
| Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson's disease over one year |
|
| A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. |
|
| Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria |
|
| Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types |
|
| Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. |
|
| Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features. |
|
| Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes. |
|
| Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases |
|
| Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease. |
|
| No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease. |
|
| Non-pharmacological interventions for Lewy body dementia: a systematic review |
|
| Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses. |
|
| Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. |
|
| Old age psychiatry |
|
| Operational criteria for senile dementia of Lewy body type (SDLT) |
|
| Operationalization of mild cognitive impairment: a graphical approach. |
|
| Optimizing mild cognitive impairment for discriminating dementia risk in the general older population. |
|
| Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease |
|
| Pathological correlates of frontotemporal lobar degeneration in the elderly |
|
| Patient and Informant Views on Visual Hallucinations in Parkinson Disease |
|
| Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions |
|
| Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. |
|
| Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry |
|
| Plasma homocysteine and cognitive decline in older hypertensive subjects. |
|
| Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. |
|
| Profiling conversation in Parkinson's disease with cognitive impairment |
|
| Propofol and electroconvulsive therapy in a patient at risk from acute intermittent porphyria. |
|
| Psychiatric features in diffuse Lewy body disease. |
|
| A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementias |
|
| Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease |
|
| Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts. |
|
| Reaching the population with dementia drugs: what are the challenges? |
|
| Reduced gastrointestinal absorption of calcium in dementia. |
|
| Regional cerebral blood flow in Parkinson's disease with and without dementia |
|
| Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT. |
|
| Regional levels of physiological α-synuclein are directly associated with Lewy body pathology. |
|
| Regulation of attention and response to therapy in dementia by butyrylcholinesterase |
|
| Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study |
|
| Revisiting DLB Diagnosis: A Consideration of Prodromal DLB and of the Diagnostic Overlap With Alzheimer Disease |
|
| Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03. |
|
| Rozpoznawanie i leczenie otępienia z ciałami Lewy'ego / Ian G. McKeith [i inni] // MP Medycna Praktyczna. Neurologia. - 5 (47) 2017, strony 21-39. |
|
| Savings from sub-groups?: Policy guidance and Alzheimer's disease treatments. |
|
| Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. |
|
| A semi-structured interview to assess visual hallucinations in older people. |
|
| Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study |
|
| SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders |
|
| Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia |
|
| Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene |
|
| Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies |
|
| Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates |
|
| Support and information needs following a diagnosis of dementia with Lewy bodies. |
|
| Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network |
|
| Symptoms associated with Lewy body disease in mild cognitive impairment |
|
| Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. |
|
| Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. |
|
| Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. |
|
| Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies |
|
